Pehub -- Lineagen Inc., Salt Lake City, Utah-based developer of genomic tests and services, is raising up to $15 million in Series B financing. The company said that existing shareholders Sanderling Ventures, vSpring Capital, PrairieGold Venture Partners and Mesa Verde Venture Partners will commit at least $5 million to the round. Lineagen previously raised $10.8 million in Series A financing.
